BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 22392420)

  • 1. Economic analysis of alvimopan for prevention and management of postoperative ileus.
    Touchette DR; Yang Y; Tiryaki F; Galanter WL
    Pharmacotherapy; 2012 Feb; 32(2):120-8. PubMed ID: 22392420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alvimopan use in laparoscopic and open bowel resections: clinical results in a large community hospital system.
    Absher RK; Gerkin TM; Banares LW
    Ann Pharmacother; 2010 Nov; 44(11):1701-8. PubMed ID: 20858770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alvimopan, a peripherally acting μ-opioid receptor antagonist, is associated with reduced costs after radical cystectomy: economic analysis of a phase 4 randomized, controlled trial.
    Kauf TL; Svatek RS; Amiel G; Beard TL; Chang SS; Fergany A; Karnes RJ; Koch M; O'Hara J; Lee CT; Sexton WJ; Slaton JW; Steinberg GD; Wilson SS; Techner L; Martin C; Moreno J; Kamat AM
    J Urol; 2014 Jun; 191(6):1721-7. PubMed ID: 24342144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic options to prevent postoperative ileus.
    Yeh YC; Klinger EV; Reddy P
    Ann Pharmacother; 2009 Sep; 43(9):1474-85. PubMed ID: 19602600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alvimopan, for postoperative ileus following bowel resection: a pooled analysis of phase III studies.
    Delaney CP; Wolff BG; Viscusi ER; Senagore AJ; Fort JG; Du W; Techner L; Wallin B
    Ann Surg; 2007 Mar; 245(3):355-63. PubMed ID: 17435541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative ileus-related morbidity profile in patients treated with alvimopan after bowel resection.
    Wolff BG; Weese JL; Ludwig KA; Delaney CP; Stamos MJ; Michelassi F; Du W; Techner L
    J Am Coll Surg; 2007 Apr; 204(4):609-16. PubMed ID: 17382220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal tract recovery in patients undergoing bowel resection: results of a randomized trial of alvimopan and placebo with a standardized accelerated postoperative care pathway.
    Ludwig K; Enker WE; Delaney CP; Wolff BG; Du W; Fort JG; Cherubini M; Cucinotta J; Techner L
    Arch Surg; 2008 Nov; 143(11):1098-105. PubMed ID: 19015469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic Impact of Alvimopan Considering Varying Definitions of Postoperative Ileus.
    Earnshaw SR; Kauf TL; McDade C; Potashman MH; Pauyo C; Reese ES; Senagore A
    J Am Coll Surg; 2015 Nov; 221(5):941-50. PubMed ID: 26353904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alvimopan for prevention of postoperative paralytic ileus in radical cystectomy patients: a cost-effectiveness analysis.
    Hilton WM; Lotan Y; Parekh DJ; Basler JW; Svatek RS
    BJU Int; 2013 Jun; 111(7):1054-60. PubMed ID: 23171223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of clinical outcomes with alvimopan in clinical practice: a national matched-cohort study in patients undergoing bowel resection.
    Delaney CP; Craver C; Gibbons MM; Rachfal AW; VandePol CJ; Cook SF; Poston SA; Calloway M; Techner L
    Ann Surg; 2012 Apr; 255(4):731-8. PubMed ID: 22388106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A meta-analysis of the effectiveness of the opioid receptor antagonist alvimopan in reducing hospital length of stay and time to GI recovery in patients enrolled in a standardized accelerated recovery program after abdominal surgery.
    Vaughan-Shaw PG; Fecher IC; Harris S; Knight JS
    Dis Colon Rectum; 2012 May; 55(5):611-20. PubMed ID: 22513441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase III trial of alvimopan, a novel, peripherally acting, mu opioid antagonist, for postoperative ileus after major abdominal surgery.
    Delaney CP; Weese JL; Hyman NH; Bauer J; Techner L; Gabriel K; Du W; Schmidt WK; Wallin BA;
    Dis Colon Rectum; 2005 Jun; 48(6):1114-25; discussion 1125-6; author reply 1127-9. PubMed ID: 15906123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of alvimopan on recovery after laparoscopic segmental colectomy.
    Obokhare ID; Champagne B; Stein SL; Krpata D; Delaney CP
    Dis Colon Rectum; 2011 Jun; 54(6):743-6. PubMed ID: 21552060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost and efficacy examination of alvimopan for the prevention of postoperative ileus.
    Nemeth ZH; Bogdanovski DA; Paglinco SR; Barratt-Stopper P; Rolandelli RH
    J Investig Med; 2017 Jun; 65(5):949-952. PubMed ID: 28566386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-institutional outcomes and cost effectiveness of using alvimopan to lower gastrointestinal morbidity after cystectomy and urinary diversion.
    Vora A; Marchalik D; Nissim H; Kowalczyk K; Bandi G; McGeagh K; Lynch J; Venkatesan K; Ghasemian R; Hwang J; Hwang MV
    Can J Urol; 2014 Apr; 21(2):7222-7. PubMed ID: 24775576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic analysis of alvimopan in North American Phase III efficacy trials.
    Bell TJ; Poston SA; Kraft MD; Senagore AJ; Delaney CP; Techner L
    Am J Health Syst Pharm; 2009 Aug; 66(15):1362-8. PubMed ID: 19635772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alvimopan accelerates gastrointestinal recovery after radical cystectomy: a multicenter randomized placebo-controlled trial.
    Lee CT; Chang SS; Kamat AM; Amiel G; Beard TL; Fergany A; Karnes RJ; Kurz A; Menon V; Sexton WJ; Slaton JW; Svatek RS; Wilson SS; Techner L; Bihrle R; Steinberg GD; Koch M
    Eur Urol; 2014 Aug; 66(2):265-72. PubMed ID: 24630419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alvimopan Provides Additional Improvement in Outcomes and Cost Savings in Enhanced Recovery Colorectal Surgery.
    Adam MA; Lee LM; Kim J; Shenoi M; Mallipeddi M; Aziz H; Stinnett S; Sun Z; Mantyh CR; Thacker JK
    Ann Surg; 2016 Jul; 264(1):141-6. PubMed ID: 26501697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of alvimopan following bowel resection: a comparison of two dosing strategies.
    Winegar B; Cox M; Truelove D; Brock G; Scherrer N; Pass LA
    Ann Pharmacother; 2013 Nov; 47(11):1406-13. PubMed ID: 24285757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alvimopan, a novel, peripherally acting mu opioid antagonist: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial of major abdominal surgery and postoperative ileus.
    Wolff BG; Michelassi F; Gerkin TM; Techner L; Gabriel K; Du W; Wallin BA;
    Ann Surg; 2004 Oct; 240(4):728-34; discussion 734-5. PubMed ID: 15383800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.